Marie-Christine N.
- Country
- Belgium
- Department
- Hematology
Research Overview
- Phase II Open-Label Study on Lenalidomide, Tafasitamab, and Rituximab in Frontline Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older
- Evaluation of Mosunetuzumab and Polatuzumab Vedotin Combination in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Patients
- Phase 3 Randomized, Double-Blind Study of Brentuximab Vedotin, Lenalidomide, and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Data & Insights
Has run more than one trial at 213 of 421 partner sites.
Specializations
B-Cell Lymphoma Research
Specialized focus on investigating treatment approaches for diffuse large B-cell lymphoma (DLBCL), particularly evaluating novel therapeutic combinations. Key interest in developing treatment strategies for previously untreated and relapsed/refractory cases.
- R-CHOP combination therapies
- Novel antibody-based treatments
- Targeted therapeutic approaches
Additional expertise in evaluating treatment outcomes for elderly DLBCL patients and investigating progression-free survival rates.
Follicular Lymphoma Studies
Dedicated research in follicular lymphoma treatment modalities, with particular emphasis on investigating combination therapies and novel treatment approaches for both untreated and relapsed/refractory cases.
- Immunotherapy combinations
- Anti-CD20 antibody treatments
- Progressive disease management
Focuses on evaluating treatment responses in high-risk patients and developing targeted therapeutic strategies.
Mantle Cell Lymphoma Innovation
Extensive work in mantle cell lymphoma (MCL) treatment development, investigating innovative therapeutic approaches for both newly diagnosed and relapsed cases.
- Autologous transplantation protocols
- Maintenance therapy strategies
- Combination treatment regimens
Specializes in evaluating minimal residual disease responses and developing targeted treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.